CIBC World Market’s TRANSITION THERAPEUTICS INC (CANADA) TTHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-19,728
Closed -$29K 1090
2016
Q2
$29K Hold
19,728
﹤0.01% 910
2016
Q1
$25K Buy
19,728
+3,855
+24% +$4.46K ﹤0.01% 855
2015
Q4
$30K Hold
15,873
﹤0.01% 862
2015
Q3
$28K Hold
15,873
﹤0.01% 854
2015
Q2
$33K Hold
15,873
﹤0.01% 885
2015
Q1
$108K Hold
15,873
﹤0.01% 778
2014
Q4
$109K Sell
15,873
-200
-1% -$1.29K ﹤0.01% 791
2014
Q3
$111K Hold
16,073
﹤0.01% 711
2014
Q2
$108K Hold
16,073
﹤0.01% 682
2014
Q1
$128K Hold
16,073
﹤0.01% 683
2013
Q4
$91K Hold
16,073
﹤0.01% 651
2013
Q3
$66K Hold
16,073
﹤0.01% 605
2013
Q2
$52K Buy
+16,073
New +$45.6K ﹤0.01% 563

Other funds holding TTHI

CIBC World Market's TTHI Position: Q3 2016 in Review

CIBC World Market sold out of TRANSITION THERAPEUTICS INC (CANADA) (TTHI) in Q3 2016, closing a stake of 19,728 shares — an estimated $29K sold.

CIBC World Market first reported a position in TTHI in Q2 2013 and held it in 13 quarters. The position peaked at $128K in Q1 2014. 2 funds tracked by Wall St. Rank hold TTHI as of Q3 2016.

  • CIBC World Market reported no remaining TRANSITION THERAPEUTICS INC (CANADA) position as of Q3 2016 after selling out during the quarter.
  • CIBC World Market sold 19,728 TRANSITION THERAPEUTICS INC (CANADA) shares in Q3 2016, an estimated $29K.
  • CIBC World Market first reported a position in TRANSITION THERAPEUTICS INC (CANADA) in Q2 2013 and held it in 13 quarters.
  • CIBC World Market's TRANSITION THERAPEUTICS INC (CANADA) position peaked at $128K in Q1 2014.
  • 2 funds tracked by Wall St. Rank held TRANSITION THERAPEUTICS INC (CANADA) as of Q3 2016.

Based on CIBC World Market's 13F filing for Q3 2016, filed 3 Nov 2016.